跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Authorized
STANDARD
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
851eaaee3982faa0
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
851eaaee3982faa0
Drug Approval Canada Name
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Product Name
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES
Status
Marketed
Status Date
2021-10-04
Original Market Date
2021-10-04
Din
02513803
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:20.00
Atc Original
L04AX07 DIMETHYL FUMARATE
Atc Name
l 04 ax 07
Aig Number
0154210002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
DIMETHYL FUMARATE
240 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
851eaaee3982faa0
Type
Standard
Back to Health Canada Approvals